ArticleAnnals of medicine and surgery (2012)2025
SuperNO2V device use in awake craniotomy patients during monitored anesthesia care: a case report.
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and importance: Awake craniotomy under monitored anesthesia care (MAC) enables real-time neurophysiologic evaluation, essential for preserving function in critical brain regions. Effective airway management is crucial, especially in patients with obesity or obstructive sleep apnea. The SuperNO2VA device, a noninvasive ventilation system, enhances oxygenation and improves patient outcomes. This case highlights its utility in managing a high-risk patient undergoing awake craniotomy. Case presentation: A 32-year-old male with a body mass index (BMI) of 33.21 kg/m Clinical discussion: This case demonstrates the SuperNO2VA device's effectiveness in managing hypoxemia in high-risk MAC procedures. Its precise oxygen delivery and noninvasive ventilation were highly advantageous in maintaining oxygenation in patients while meeting fire safety requirements. Conclusion: The SuperNO2VA device is a valuable tool for airway management during awake craniotomy in patients with challenging physiologic profiles. Its ability to stabilize oxygenation highlights its potential for broader applications in high-risk surgical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.